Sagittal abdominal diameter is a strong anthropometric marker of insulin resistance and hyperproinsulinemia in obese men

Diabetes Care

Volumn 27, Issue 8, 2004, Pages 2041-2046

  Risérus, Ulf ^a,c   Ärnlöv, Johan ^a   Brismar, Kerstin ^b   Zethelius, Björn ^a   Berglund, Lars ^a   Vessby, Bengt ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; PROINSULIN; SOMATOMEDIN BINDING PROTEIN 1;

ABDOMEN; ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ANTHROPOMETRY; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; EUGLYCEMIC HYPERINSULINEMIC CLAMP; GLUCOSE TOLERANCE TEST; HIGH RISK POPULATION; HUMAN; HYPERPROINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULINEMIA; MAJOR CLINICAL STUDY; MORTALITY; MULTIPLE REGRESSION; NON INVASIVE MEASUREMENT; OBESITY; PREDICTION; PROTEIN BLOOD LEVEL; SAGITTAL ABDOMINAL DIAMETER; SWEDEN; WAIST GIRTH; WAIST HIP RATIO;

ABDOMEN; ADULT; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; BODY SIZE; HUMANS; HYPERINSULINISM; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; PROINSULIN; RISK FACTORS;

EID: 3342957096     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.8.2041     Document Type: Article

References (51)

1. National Institute of Diabetes and Digestive and Kidney Diseases: Overweight, obesity, and health risk: National Task Force on the prevention and treatment of obesity. Arch Intern Med 160:898-904, 2000
2. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians. N Engl J Med 329:1988-1992, 1993
3. Ginsberg HN: Insulin resistance and cardiovascular disease. J Clin Invest 106:453-458, 2000
4. Reaven G: Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation 106:286-288, 2002
5. Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Hales CN, Laakso M: Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects. Diabetologia 38:1176-1182, 1995
6. Kahn SE, Leonetti DL, Prigeon RL, Boyko EJ, Bergstrom RW, Fujimoto WY: Proinsulin as a marker for the development of NIDDM in Japanese-American men. Diabetes 44:173-179, 1995
7. Zethelius B, Byberg L, Hales CN, Lithell H, Berne C: Proinsulin and acute insulin response independently predict type 2 diabetes mellitus in men: report from 27 years of follow-up study. Diabetologia 46: 20-26, 2003
8. Zethelius B, Byberg L, Hales CN, Lithell H, Berne C: Proinsulin is an independent predictor of coronary heart disease: report from a 27-year follow-up study. Circulation 105:2153-2158, 2002
9. Yudkin JS, May M, Elwood P, Yarnell JW, Greenwood R, Davey Smith G: Concentrations of proinsulin like molecules predict coronary heart disease risk independently of insulin: prospective data from the Caerphilly Study. Diabetologia 45:327-336, 2002
10. McLaughlin TL, Reaven GM: Beyond type 2 diabetes: the need for a clinically useful way to identify insulin resistance (Editorial). Am J Med 114:501-502, 2003
11. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G: Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 139:802-809, 2003
12. Despres JP: Abdominal obesity as important component of insulin-resistance syndrome. Nutrition 9:452-459, 1993
13. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G: Insulin resistance and hypersecretion in obesity: European Group for the Study of Insulin Resistance (EGIR).J Clin Invest 100:1166-1173, 1997
14. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, Nadeau A, Lupien PJ: Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 73:460-468, 1994
15. Richelsen B, Pedersen SB: Associations between different anthropometric measurements of fatness and metabolic risk parameters in non-obese, healthy, middle-aged men. Int J Obes 19:169-174, 1995
16. Ohrvall M, Berglund L, Vessby B: Sagittal abdominal diameter compared with other anthropometric measurements in relation to cardiovascular risk. Int J Obes 24:497-501, 2000
17. Kahn HS, Austin H, Williamson DF, Arensberg D: Simple anthropometric indices associated with ischemic heart disease. J Clin Epidemiol 49:1017-1024, 1996
18. Gustat J, Elkasabany A, Srinivasan S, Berenson GS: Relation of abdominal height to cardiovascular risk factors in young adults: the Bogalusa heart study. Am J Epidemiol 151:885-891, 2000
19. Kahn HS, Simoes EJ, Koponen M, Hanzlick R: The abdominal diameter index and sudden coronary death in men. Am J Cardiol 78:961-964, 1996
20. Seidell JC, Andres R, Sorkin JD, Muller DC: The sagittal waist diameter and mortality in men: the Baltimore longitudinal study on aging. Int J Obes 18:61-67, 1994
21. Kvist H, Chowdhury B, Grangård U, Tylén U, Sjöström L: Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations. Am J Clin Nutr 48:1351-1361, 1988
22. van der Kooy K, Leenen R, Seidell JC, Deurenberg P, Visser M: Abdominal diameters as indicators of visceral fat: comparison between magnetic resonance imaging and anthropometry. Br J Nutr 70: 47-58, 1993
23. Clasey JL, Bouchard C, Teates CD, Riblett JE, Thorner MO, Hartman ML, Weltman A: The use of anthropometric and dual-energy x-ray absorptiometry (DXA) measures to estimate total abdominal and abdominal visceral fat in men and women. Obes Res 7:256-264, 1999
24. Montague CT, O'Rahilly S: The perils of portliness: causes and consequences of visceral adiposity. Diabetes 49:883-888, 2000
25. Han TS, van Leer EM, Seidell JC, Lean ME: Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 311:1401-1405, 1995
26. Despres JP, Lemieux I, Prud'homme D: Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ 322:716-720, 2001
27. Gibson JM, Westwood M, Young RJ, White A: Reduced insulin-like growth factor binding protein-1 (IGFBP-1) levels correlate with increased cardiovascular risk in noninsulin dependent diabetes mellitus (NIDDM). J Clin Endocrinol Metab 81:860-863, 1996
28. Heald AH, Cruickshank JK, Riste LK, Cade JE, Anderson S, Greenhalgh A, Sampayo J, Taylor W, Fraser W, White A, Gibson JM: Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations. Diabetologia 44:333-339, 2001
29. Riserus U, Arner P, Brismar K, Vessby B: Treatment with dietary trans 10cis 12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 25:1516-1521, 2002
30. Póvoa G, Roovete A, Hall K: Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol 107:563-570, 1984
31. Morrison DF: The multivariate analysis of variance. In Multivariate Statistical Methods. New York, McGraw-Hill, 1976, p. 176-179
32. Strazzullo P, Barba G, Cappuccio FP, Siani A, Trevisan M, Farinaro E, Pagano E, Barbato A, Iacone R, Galletti F: Altered renal sodium handling in men with abdominal adiposity: a link to hypertension. J Hypertens 19:2157-2164, 2001
33. Kumlin L, Dimberg L, Mårin P: Ratio of adominal to height is a strong indicator of coronary risk (Letter). BMJ 314:830, 1997
34. Sjostrom CD, Lissner L, Sjostrom L: Relationships between changes in body composition and changes in cardiovascular risk factors: the SOS intervention study: Swedish Obese Subjects. Obes Res 5:519-530, 1997
35. Hwu CM, Hsiao CF, Sheu WH, Pei D, Tai TY, Quertermous T, Rodriguez B, Pratt R, Chen YD, Ho LT: Sagittal abdominal diameter is associated with insulin sensitivity in Chinese hypertensive patients and their siblings. J Hum Hypertens 17:193-198, 2003
36. Weidner MD, Gavigan KE, Tyndall GL, Hickey MS, McCammon MR, Houmard JA: Which anthropometric indices of regional adiposity are related to the insulin resistance of aging? Int J Obes 19:325-330, 1995
37. Nordhamn K, Sodergren E, Olsson E, Karlstrom B, Vessby B, Berglund L: Reliability of anthropometric measurements in overweight and lean subjects: consequences for correlations between anthropometric and other variables. Int J Obes 24:652-657, 2000
38. Brismar K, Grill V, Efendic S, Hall K: The insulin-like growth factor binding protein-1 in low and high insulin responders before and during dexamethasone treatment. Metabolism 40:728-732, 1991
39. Lee PDK, Jensen MD, Divertie GD, Heiling VJ, Katz HH, Conover CC: Insulin-like growth factor-binding protein-1 response to insulin during suppression of endogenous insulin secretion. Metabolism 42:409-414, 1993
40. Kahn HS, Williamson DF: Sagittal abdominal diameter (Letter). Int J Obes 17: 669, 1993
41. Sjöstrom L, Lönn L, Chowdhury B: The sagittal diameter is a valid marker of the visceral adipose tissue volume. In Progress in Obesity Research. Angel A, Andersson H, Bouchard C, Lau L, Leiter L, Mendelson R, Eds. London, John Libbey, 1996, p. 309-319
42. Asayama K, Dobashi K, Hayashibe H, Kodera K, Uchida N, Nakane T, Araki T, Nakazawa S: Threshold values of visceral fat measures and their anthropometric alternatives for metabolic derangement in Japanese obese boys. Int J Obes 26:208-213, 2002
43. Kissebah AH: Insulin resistance in visceral obesity. Int J Obes 15 (Suppl. 2):109-115, 1991
44. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM: Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 96: 88-98, 1995
45. Wagenknecht LE, Langefeld CD, Scherzinger AL, Norris JM, Haffner SM, Saad MF, Bergman RN: Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 52:2490-2496, 2003
46. Groop L, Forsblom C, Lehtovirta M, Tuomi T, Karanko S, Nissen M, Ehmstrom BO, Forsen B, Isomaa B, Snickars B, Taskinen MR: Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes 45:1585-1593, 1996
47. Bouchard C, Rice T, Lemieux S, Despres JP, Perusse L, Rao DC: Major gene for abdominal visceral fat area in the Quebec family study. Int J Obes Relat Metab Disord 20:420-427, 1996
48. Davey G, Ramachandran A, Snehalatha C, Hitman GA, McKeigue PM: Familial aggregation of central obesity in Southern Indians. Int J Obes 24:1523-1527, 2000
49. Kohrt WM, Kirwan JP, Staten MA, Bourey RE, King DS, Holloszy JO: Insulin resistance in aging is related to abdominal obesity. Diabetes 42:273-281, 1993
50. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356-359, 2002
51. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350, 2001